IART insider trading
NasdaqGS HealthcareINTEGRA LIFESCIENCES HOLDINGS CORP: insider trade history from SEC Form 4 filings.
About INTEGRA LIFESCIENCES HOLDINGS CORP
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Company website: www.integralife.com
IART insider activity at a glance
FilingIQ tracks 1,341 insider transactions for IART in filings since Jan 5, 2015. The most recent transaction is dated Sep 1, 2026.
Across the full history, 11 open-market purchases
and 164 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IART insider trades is 58.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IART Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IART?
- FilingIQ tracks 1,341 Form 4 insider transactions for IART (INTEGRA LIFESCIENCES HOLDINGS CORP), covering filings from Jan 5, 2015 onwards. 1 of those are dated within the last 90 days.
- Are IART insiders net buyers or net sellers?
- Across the full Form 4 history for IART, 11 transactions (1%) were open-market purchases and 164 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IART insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IART in?
- INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $914.67M.
Methodology & sources
Every IART insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.